Pfenex (PFNX) Tops Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. DMART:IN
8. HUM
9. CSCO
10. KTOS

Go back to Pfenex (PFNX) Tops Q1 EPS by 10c

Pfenex Reports First Quarter 2016 Results and Provides Business Update

May 9, 2016 4:05 PM EDT

SAN DIEGO, May 9, 2016 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value and difficult to manufacture proteins, today reported financial results for the first quarter ended March 31, 2016 and provided a business update.

"Pfenex continued to make solid progress in the first quarter," stated Bertrand C. Liang, chief executive officer of Pfenex.  "Today we announced the positive top-line data from our PF708 initial bioequivalence... More